Codelab Capital AS

Codelab Capital AS R&D Expenses

Research & Development Expenses of Codelab Capital AS (CODE.OL) as of Nov 20, 2026.

R&D Expenses

0.00NOK

Last updated:

Research & Development Expenses of Codelab Capital AS is 2025 0.00 NOK. Research & Development Expenses of Codelab Capital AS was 2024 8.19 M NOK. It decreases by % lower compared to the previous year.

The Codelab Capital AS R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2018
-35.00 M NOK
Jan 1, 2019
-27.60 M NOK
Jan 1, 2020
-31.40 M NOK
Jan 1, 2021
82.33 M NOK
Jan 1, 2022
39.30 M NOK
Jan 1, 2023
16.21 M NOK
Jan 1, 2024
8.19 M NOK
Jan 1, 2025
0.00 NOK
The Codelab Capital AS R&D Expenses history
YEARR&D ExpensesYoY
0.00NOK-100.00%
8.19 MNOK-49.51%
16.21 MNOK-58.75%
39.30 MNOK-52.26%
82.33 MNOK-362.19%
-31.40 MNOK+13.77%
-27.60 MNOK-21.14%
-35.00 MNOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Codelab Capital AS Stock analysis

What does Codelab Capital AS do? CodeLab Capital AS generates revenue through its cloud-based SaaS, PaaS, and IaaS offerings, primarily targeting healthcare providers and patients. The company's main products include the PatientSky 360 Platform, electronic health record systems, and medication modules, which are delivered as Software-as-a-Service, Platform-as-a-Service, and Value-Added Services solutions. Healthcare providers purchase these integrated platforms and modules to enhance patient care and operational efficiency, while patients benefit from the platform's features through their healthcare providers' implementation. The PatientSky 360 Platform serves as the central product, providing scalable building blocks for both internally developed and partner-created healthcare software modules. This platform enables healthcare organizations to customize and expand their digital solutions without extensive development costs. The firm's Value-Added Services further support clients by enhancing the functionality and integration of the core platform and its modules. CodeLab Capital AS focuses on delivering comprehensive healthcare software solutions that combine infrastructure, platform, and application services. By offering these services under the SaaS, PaaS, and IaaS models, the company ensures that healthcare providers can access and scale their digital tools as needed, driving adoption and recurring revenue streams from their clients. Codelab Capital AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codelab Capital AS stock

On Eulerpool you can find the complete historical development of Research & Development Expenses Codelab Capital AS since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's NOK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Codelab Capital AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Codelab Capital AS

All Key Metrics — Codelab Capital AS